- Home
- ZYXI vs RAND Comparison
ZYXI vs RAND Comparison
Compare ZYXI & RAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYXI
- RAND
- Stock Information
- Founded
- ZYXI 1996
- RAND 1969
- Country
- ZYXI United States
- RAND United States
- Employees
- ZYXI N/A
- RAND N/A
- Industry
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- RAND Finance: Consumer Services
- Sector
- ZYXI Health Care
- RAND Finance
- Exchange
- ZYXI Nasdaq
- RAND Nasdaq
- Market Cap
- ZYXI 66.5M
- RAND 57.6M
- IPO Year
- ZYXI N/A
- RAND N/A
- Fundamental
- Price
- ZYXI $2.49
- RAND $15.48
- Analyst Decision
- ZYXI Buy
- RAND
- Analyst Count
- ZYXI 3
- RAND 0
- Target Price
- ZYXI $6.00
- RAND N/A
- AVG Volume (30 Days)
- ZYXI 204.8K
- RAND 6.1K
- Earning Date
- ZYXI 07-24-2025
- RAND 08-05-2025
- Dividend Yield
- ZYXI N/A
- RAND 7.47%
- EPS Growth
- ZYXI N/A
- RAND 39.77
- EPS
- ZYXI N/A
- RAND 3.12
- Revenue
- ZYXI $172,401,000.00
- RAND $8,499,970.00
- Revenue This Year
- ZYXI N/A
- RAND N/A
- Revenue Next Year
- ZYXI $19.55
- RAND N/A
- P/E Ratio
- ZYXI N/A
- RAND $4.98
- Revenue Growth
- ZYXI N/A
- RAND 12.52
- 52 Week Low
- ZYXI $1.66
- RAND $14.01
- 52 Week High
- ZYXI $10.62
- RAND $31.89
- Technical
- Relative Strength Index (RSI)
- ZYXI 56.22
- RAND 42.20
- Support Level
- ZYXI $1.99
- RAND $15.15
- Resistance Level
- ZYXI $2.47
- RAND $15.75
- Average True Range (ATR)
- ZYXI 0.15
- RAND 0.52
- MACD
- ZYXI 0.04
- RAND 0.14
- Stochastic Oscillator
- ZYXI 91.46
- RAND 36.67
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
About RAND Rand Capital Corporation
Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. The company's investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.